Literature DB >> 8123854

Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas.

R J Molot1, T C Meeker, C T Wittwer, S L Perkins, G H Segal, A S Masih, R C Braylan, C R Kjeldsberg.   

Abstract

Flow immunophenotyping, DNA content analysis, and polymerase chain reaction (PCR) amplification for t(11;14) and t(14;18) were performed on 11 cases of typical mantle cell lymphoma (MCL), 5 cases of apparent MCL with proliferation centers (MCL-PC), and 5 cases of small lymphocytic lymphoma (SLL). Immunophenotyping showed IgM (P < .001), Ig light (P < .001), and CD20 (P < .001) expression to be more intense in MCL than in SLL. In MCL-PC, the mean intensity of IgM, Ig light chain, and CD20 expression was intermediate to the intensities observed in MCL and SLL. Furthermore, in contrast to SLL, all MCL and 4 of 5 MCL-PC cases exhibited stronger CD20 than CD19 expression. CD10 expression was not observed in any case and CD5 expression was present in all SLL and MCL-PC cases and in 9 of 11 MCL cases. DNA content analysis showed an S-phase fraction of less than 3% in all cases studied and, except for 1 MCL case, all lymphomas were DNA diploid. The t(11;14) breakpoint junctions involving the bcl-1 major translocation cluster were amplified by PCR in 4 of 11 (36%) MCL cases and in none of the MCL-PC or SLL cases. The t(14;18) involving the bcl-2 major breakpoint region was not identified by PCR in any case. We conclude that the level of expression of surface antigens and the rapid detection of t(11;14) by PCR are potentially useful for distinguishing MCL and SLL in the clinical setting. Further investigations as to the biologic relationship between MCL, MCL-PC, and SLL, and the utility of t(11;14) PCR in these lymphomas are warranted.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8123854

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Molecular pathology of low grade malignant lymphomas.

Authors:  H Ratech
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

2.  Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients.

Authors:  Carsten Schrader; Peter Meusers; Günter Brittinger; Dirk Janssen; Afshin Teymoortash; Jens U Siebmann; Reza Parwaresch; Markus Tiemann
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

3.  Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.

Authors:  Habil Zare; Ali Bashashati; Robert Kridel; Nima Aghaeepour; Gholamreza Haffari; Joseph M Connors; Randy D Gascoyne; Arvind Gupta; Ryan R Brinkman; Andrew P Weng
Journal:  Am J Clin Pathol       Date:  2012-01       Impact factor: 2.493

4.  Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders.

Authors:  J Z Gong; S Zheng; R Chiarle; C De Wolf-Peeters; G Palestro; G Frizzera; G Inghirami
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.

Authors:  R Suzuki; K Takemura; M Tsutsumi; S Nakamura; N Hamajima; M Seto
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Development of expression-based biomarkers of Dasatinib response in hematologic malignancies.

Authors:  Monica K Akre; Amit Mitra; Wen Wang; Chad L Myers; Brian Van Ness
Journal:  Blood Cancer J       Date:  2017-12-15       Impact factor: 11.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.